Hongri Pharmaceutical: The company holds a 50.98% stake in Wantai, and its business scale accounts for a relatively small proportion at the consolidated financial statement level.

NightAirdropper · 2026-03-26T20:55:26+00:00

Hongri Pharmaceutical responded to questions about Wantai Auxiliary Materials on the investor interaction platform, emphasizing that it holds a 50.98% stake and has a relatively small business scale, which does not meet the standards for individual disclosure. They confirmed that Wantai Auxiliary Materials has legitimate production qualifications and denied the existence of any operations without substantive business activity.

NightAirdropper

2026-03-26 20:55:26

Abstract generation in progress

Everyday Economic News AI Express: An investor asked on the investor interaction platform: The company states that Wantai Auxiliary Materials has production qualifications and export business, but has never separately disclosed its revenue, profit, or net assets, only grouping it into the raw materials segment. The minimum bid price for this 100% equity stake is only 19.37 million yuan, which is very low. Please clarify: What are the actual revenues, net profits, net assets, and number of employees of Wantai Auxiliary Materials over the past three years? Are there any cases of no substantial operations, only acting as a bookkeeping or benefit transfer channel?

Hongri Pharmaceutical (300026.SZ) stated on March 26 on the investor interaction platform: The company holds a 50.98% stake in Wantai, and its business scale accounts for a relatively small proportion in the company’s consolidated financial statements, not meeting the standard for separate disclosure. As of now, Wantai Auxiliary Materials has valid production qualifications and is conducting related business, with no cases of “no substantial operations, only acting as a bookkeeping channel.”

(Reporter Wang Hanli)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Verify before use. Operate at your own risk.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes